Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription
Journal of Medical Virology · 2024-05 · 96 (5)
DOI: 10.1002/jmv.29669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 21.05.2024. Verfasst von Fang Ren und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China. Hauptthemen laut MEDLINE: Furocoumarins, Hepatitis B virus, Hepatitis B Surface Antigens, DNA, Circular. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Natural Science Foundation, Chongqing Postdoctoral Science Foundation.
Abstract (Originalsprache)
Chronic hepatitis B virus (HBV) infection remains a significant global health challenge due to its link to severe conditions like HBV‐related cirrhosis and hepatocellular carcinoma (HCC). Although current treatments effectively reduce viral levels, they have limited impact on certain HBV elements, namely hepatitis B surface antigen (HBsAg) and covalently closed circular DNA (cccDNA). This highlights the urgent need for innovative pharmaceutical and biological interventions that can disrupt HBsAg production originating from cccDNA. In this study, we identified a natural furanocoumarin compound, Imperatorin, which markedly inhibited the expression of HBsAg from cccDNA, by screening a library of natural compounds derived from Chinese herbal medicines using ELISA assay and qRT‐PCR. The pharmacodynamics study of Imperatorin was explored on HBV infected HepG2‐NTCP/PHHs and HBV‐infected humanized mouse model. Proteome analysis was performed on HBV infected HepG2‐NTCP cells following Imperatorin treatment. Molecular docking and bio‐layer interferometry (BLI) were used for finding the target of Imperatorin. Our findings demonstrated Imperatorin remarkably reduced the level of HBsAg, HBV RNAs, HBV DNA and transcriptional activity of cccDNA both in vitro and in vivo. Additionally, Imperatorin effectively restrained the actions of HBV promoters responsible for cccDNA transcription. Mechanistic study revealed that Imperatorin directly binds to ERK and subsequently interfering with the activation of CAMP response element‐binding protein (CREB), a crucial transcriptional factor for HBV and has been demonstrated to bind to the PreS2/S and X promoter regions of HBV. Importantly, the absence of ERK could nullify the antiviral impact triggered by Imperatorin. Collectively, the natural compound Imperatorin may be an effective candidate agent for inhibiting HBsAg production and cccDNA transcription by impeding the activities of HBV promoters through ERK‐CREB axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.
- Chongqing Key Laboratory of Sichuan-Chongqing Co-construction for Diagnosis and Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, Chongqing, China.
- The Key Laboratory of Molecular Biology of Infectious Diseases designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao.
- Sichuan Key Medical Laboratory of New Drug Discovery and Drug Ability Evaluation, Key Laboratory of Medical Electrophysiology of Ministry of Education, School of Pharmacy, Southwest Medical University, Luzhou, China.
ORCID-Profile: Fang Ren
Förderung
- National Natural Science Foundation of China
- Chongqing Natural Science Foundation
- Chongqing Postdoctoral Science Foundation
- Chongqing Science and Technology Foundation
- China Postdoctoral Science Foundation
- College Project of Chengdu University of Traditional Chinese Medicine
Zitieren
APA
Ren, F., Zhao, S., He, X., Lo, H., Wong, V. K. W., Law, B. Y. K., Wu, A., & Zhang, J. (2024). Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription. Journal of Medical Virology, 96(5). https://doi.org/10.1002/jmv.29669
Vancouver
Ren F, Zhao S, He X, Lo H, Wong VKW, Law BYK, et al. Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription. Journal of Medical Virology. 2024;96(5). doi:10.1002/jmv.29669
BibTeX
@article{Ren2024,
author = {Ren, Fang and Zhao, Shiqiao and He, Xin and Lo, Hanghong and Wong, Vincent Kam Wai and Law, Betty Yuen Kwan and Wu, Anguo and Zhang, Juan},
title = {Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription},
journal = {Journal of Medical Virology},
year = {2024},
volume = {96},
number = {5},
doi = {10.1002/jmv.29669}
}
EUVIMED